Journal: Materials Today Bio
Article Title: Sprayable asymmetric hydrogel prevents postoperative pleural adhesions via physical and biological dual therapy
doi: 10.1016/j.mtbio.2026.103297
Figure Lengend Snippet: The efficacy of HP/L@HLS hydrogel was validated in vitro. (a) MeT-5A cells treated with HP/L@HLS hydrogel were subjected to immunofluorescence staining to determine fibrosis- and MMT-related protein expression. (b) The corresponding relative fluorescence intensity quantifications presented in the panel below (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs TGF-β group, # P < 0.05, ## P < 0.01, ### P < 0.001 vs indicated group). (c) Schematic diagram of MeT-5A cells treated with HP/L@HLS. (d) HFL1 cells treated with HP/L@HLS hydrogel were subjected to immunofluorescence staining to determine fibrosis-related protein expression. (e) The corresponding relative fluorescence intensity quantifications presented in the panel to the right (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs TGF-β group, # P < 0.05, ### P < 0.001 vs indicated group). (f) Schematic diagram of HFL1 cells treated with HP/L@HLS. (g) M1-type macrophages treated with HP/L@HLS hydrogel were subjected to ELISA to determine IL-1β secretion levels (n = 3) (mean ± SD; *** P < 0.001 vs M1 group, ## P < 0.01, ### P < 0.001 vs indicated group). (h) M1-type macrophages treated with HP/L@HLS hydrogel were subjected to ELISA to determine TNF-α secretion levels (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01 vs M1 group). (i) Abundance of IL-1β, IL-6, TNF-α, and CXCL9 in M1 macrophages after 24 h of HP/L@HLS hydrogel treatment (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs M1 group, # P < 0.05, ### P < 0.001 vs indicated group). (j) Abundance of TGF-β, PDGF, and CTGF in M2 macrophages after 24 h of HP/L@HLS hydrogel treatment (n = 3) (mean ± SD; * P < 0.05, ** P < 0.01, *** P < 0.001 vs M1 group, # P < 0.05 vs indicated group). (k) Schematic diagram of Raw264.7 cells treated with HP/L@HLS.
Article Snippet: MeT-5A and HFL1 cells were treated with 5 ng/mL transforming growth factor-β1 (TGF-β1) (MedChemExpress, USA) for 24 h to induce fibrotic changes.
Techniques: In Vitro, Immunofluorescence, Staining, Expressing, Fluorescence, Enzyme-linked Immunosorbent Assay